IL52101A0 - New pharmaceutical compositions containing ergotamine derivatives - Google Patents

New pharmaceutical compositions containing ergotamine derivatives

Info

Publication number
IL52101A0
IL52101A0 IL52101A IL5210177A IL52101A0 IL 52101 A0 IL52101 A0 IL 52101A0 IL 52101 A IL52101 A IL 52101A IL 5210177 A IL5210177 A IL 5210177A IL 52101 A0 IL52101 A0 IL 52101A0
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
compositions containing
new pharmaceutical
ergotamine derivatives
derivatives
Prior art date
Application number
IL52101A
Other versions
IL52101A (en
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of IL52101A0 publication Critical patent/IL52101A0/en
Publication of IL52101A publication Critical patent/IL52101A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/02Ergot alkaloids of the cyclic peptide type
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/48Ergoline derivatives, e.g. lysergic acid, ergotamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL52101A 1976-05-17 1977-05-16 Pharmaceutical compositions containing dihydroergotamine and etilefrine IL52101A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762621906 DE2621906A1 (en) 1976-05-17 1976-05-17 NEW THERAPEUTIC MIXTURE AND METHOD FOR PRODUCING IT

Publications (2)

Publication Number Publication Date
IL52101A0 true IL52101A0 (en) 1977-07-31
IL52101A IL52101A (en) 1980-01-31

Family

ID=5978199

Family Applications (1)

Application Number Title Priority Date Filing Date
IL52101A IL52101A (en) 1976-05-17 1977-05-16 Pharmaceutical compositions containing dihydroergotamine and etilefrine

Country Status (22)

Country Link
JP (1) JPS52139730A (en)
AT (1) AT366574B (en)
AU (1) AU513718B2 (en)
BE (1) BE854694A (en)
CA (1) CA1088865A (en)
CS (1) CS207455B2 (en)
DE (1) DE2621906A1 (en)
ES (1) ES458819A1 (en)
FR (1) FR2351657A1 (en)
GB (1) GB1565447A (en)
GR (1) GR72995B (en)
HK (1) HK3283A (en)
HU (1) HU175167B (en)
IE (1) IE45197B1 (en)
IL (1) IL52101A (en)
MY (1) MY8400062A (en)
NL (1) NL177981C (en)
NZ (1) NZ184111A (en)
PH (1) PH20257A (en)
PT (1) PT66552B (en)
SE (1) SE425545B (en)
ZA (1) ZA772935B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2935515A1 (en) * 1979-09-03 1981-03-19 Fa. Dr. Willmar Schwabe, 7500 Karlsruhe MEDICINAL PRODUCT
JPH0227013U (en) * 1988-08-10 1990-02-22
CN1187039C (en) 1999-03-26 2005-02-02 波曾公司 High potency dihydroergotamine compositions

Also Published As

Publication number Publication date
DE2621906A1 (en) 1977-12-01
IL52101A (en) 1980-01-31
PT66552B (en) 1979-09-03
JPS628413B2 (en) 1987-02-23
AT366574B (en) 1982-04-26
PT66552A (en) 1977-06-01
HK3283A (en) 1983-01-20
ES458819A1 (en) 1978-08-01
ATA347677A (en) 1981-09-15
CS207455B2 (en) 1981-07-31
IE45197L (en) 1977-11-17
MY8400062A (en) 1984-12-31
NZ184111A (en) 1980-02-21
AU513718B2 (en) 1980-12-18
JPS52139730A (en) 1977-11-21
AU2516977A (en) 1978-11-23
BE854694A (en) 1977-11-16
NL177981C (en) 1986-01-02
IE45197B1 (en) 1982-07-14
SE7705340L (en) 1977-11-18
DE2621906C2 (en) 1988-04-21
NL7705306A (en) 1977-11-21
GB1565447A (en) 1980-04-23
ZA772935B (en) 1979-01-31
HU175167B (en) 1980-05-28
SE425545B (en) 1982-10-11
NL177981B (en) 1985-08-01
PH20257A (en) 1986-11-14
GR72995B (en) 1984-01-24
FR2351657A1 (en) 1977-12-16
FR2351657B1 (en) 1980-01-18
CA1088865A (en) 1980-11-04

Similar Documents

Publication Publication Date Title
ZA771091B (en) Pharmaceutical compositions
ZA774920B (en) Pharmaceutical compositions
PT66622B (en) Pharmaceutical compositions
JPS52113976A (en) Pharmaceutical composition
JPS5362838A (en) Pharmaceutical composition
ZA771003B (en) Pharmaceutical compositions containing pyrethrinoides
AU3111677A (en) Pharmaceutical compositions
IL51314A0 (en) New pharmaceutical compositions containing disodium cromoglycate
PH14141A (en) Pharmaceutical composition containing dipeptide derivatives
AU3152677A (en) Pharmaceutical composition
NZ186147A (en) Sterolin pharmaceutical compositions
NZ184539A (en) 2-bromo-6-fluoro-n-2-imidazolidinylidene-benzamine pharmaceutical compositions
AU2609277A (en) Pharmaceutical compositions
AU2649977A (en) Pharmaceutical composition
JPS5356634A (en) Pharmaceutical composition
IL52103A0 (en) Pharmaceutical compositions containing naphthopyrane derivvatives
GB1547206A (en) Pharmaceutical compositions
ZA772612B (en) Pharmaceutical compositions
AU2574877A (en) Pharmaceutical compositions
IL53146A0 (en) Pharmaceutical compositions containing certain pyrrolidone derivatives
IL52101A0 (en) New pharmaceutical compositions containing ergotamine derivatives
JPS5325579A (en) Pharmaceutical compound
HK3984A (en) Pharmaceutical compositions
JPS5283918A (en) Pharmaceutical composition
ZA771408B (en) Pharmaceutical compositions